Effect of intravenous gadolinium-DTPA on diffusion-weighted imaging for prostate lesions and normal tissue at 3.0-Tesla magnetic resonance imaging

Acta Radiologica

Volumn 52, Issue 5, 2011, Pages 575-580

  Liu, Xiaohang ^a   Zhou, Liangping ^a   Peng, Weijun ^a   Qian, Min ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Diffusion weighted imaging (DWI); Gadolinium DTPA; Magnetic resonance imaging (MRI); Perfusion; Prostate

Indexed keywords

APPARENT DIFFUSION COEFFICIENT; B VALUE; BENIGN LESION; CONTRAST MATERIAL; CONTRAST TO NOISE RATIO; DCE-MRI; DIFFUSION WEIGHTED IMAGING; DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING; ECHO PLANAR IMAGING; GADOLINIUM-DTPA; GD-DTPA; NORMAL TISSUE; PERFUSION; PROSTATE; PROSTATE CANCERS; REGIONS OF INTEREST; SIGNAL TO NOISE; STATISTICAL DIFFERENCES; T-TESTS;

ANALOG TO DIGITAL CONVERSION; DISEASES; GADOLINIUM; IMAGE QUALITY; RESONANCE; SIGNAL TO NOISE RATIO; SURFACE DIFFUSION; TISSUE;

MAGNETIC RESONANCE IMAGING;

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

AGED; ARTICLE; COMPUTER ASSISTED DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; PROSTATE TUMOR; PROSTATECTOMY; TRANSURETHRAL RESECTION;

AGED; AGED, 80 AND OVER; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; GADOLINIUM DTPA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 80051566466     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1258/ar.2011.100416     Document Type: Article

References (20)

1. Clinicopathological statistics on registered prostate cancer patients in Japan: 2000 report from the Japanese Urological Association. Int J Urol 2005;12:46-61
2. Quinn M, Babb P. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part II: Individual countries. BJU Int 2002;90:174-84
3. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827-41
4. Kurhanewicz J, Vigneron D, Carroll P, et al. Multiparametric magnetic resonance imaging in prostate cancer: Present and future. Curr Opin Urol 2008;18:71-7
5. Kim JK, Jang YJ, Cho G. Multidisciplinary functional MR imaging for prostate cancer. Korean J Radiol 2009;10:535-51
6. Miao H, Fukatsu H, Ishigaki T. Prostate cancer detection with 3-T MRI: Comparison of diffusion-weighted and T2-weighted imaging. Eur J Radiol 2007;61:297-302
7. Kim CK, Park BK, Kim B. Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer. Am J Roentgenol 2010; 194:1461-9
8. Kuhl CK, Gieseke J, von Falkenhausen M, et al. Sensitivity encoding for diffusion-weighted MR imaging at 3.0 T: Intraindividual comparative study. Radiology 2005;234:517-26
9. Kim CK, Park BK, Lee HM, et al. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: Preliminary results. Invest Radiol 2007;42:842-7
10. Firat AK, Sanli B, Karakas HM, et al. The effect of intravenous gadolinium-DTPA on diffusion-weighted imaging. Neuroradiology 2006;48:465-70
11. Yamada K, Kubota H, Kizu O, et al. Effect of intravenous gadolinium-DTPA on diffusion-weighted images: Evaluation of normal brain and infarcts. Stroke 2002;33:1799-802
12. Fitzek C, Mentzel HJ, Fitzek S, et al. Echoplanar diffusion-weighted MRI with intravenous gadolinium-DTPA. Neuroradiology 2003;45:592-7
13. Zhong J, Kennan RP, Fulbright RK, et al. Quantification of intravascular and extravascular contributions to BOLD effects induced by alteration in oxygenation or intravascular contrast agents. Magn Reson Med 1998;40:526-36
14. Villeirs GM, L Verstraete K, De Neve WJ, et al. Magnetic resonance imaging anatomy of the prostate and periprostatic area: A guide for radiotherapists. Radiother Oncol 2005;76:99-106
15. Franiel T, Ludemann L, Rudolph B, et al. Prostate MR imaging: Tissue characterization with pharmacokinetic volume and blood flow parameters and correlation with histologic parameters. Radiology 2009;252:101-8
16. Noworolski SM, Henry RG, Vigneron DB, et al. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI. Magn Reson Med 2005;53:249-55
17. Franiel T, Ludemann L, Rudolph B, et al. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence. Invest Radiol 2008;43:481-7
18. Choi JS, Kim MJ, Choi JY, et al. Diffusion-weighted MR imaging of liver on 3.0-Tesla system: Effect of intravenous administration of gadoxetic acid disodium. Eur Radiol 2010;20:1052-60
19. Ikonen S, Kivisaari L, Tervahartiala P, et al. Prostatic MR imaging. Accuracy in differentiating cancer from other prostatic disorders. Acta Radiol 2001;42:348-54
20. Chen G, Jespersen SN, Pedersen M, et al. Intravenous administration of Gd-DTPA prior to DWI does not affect the apparent diffusion constant. Magn Reson Imaging 2005;23:685-9